Figure 1 from Prognostic Impact of Immune-Related Adverse Events on Combination Immune Checkpoint/Tyrosine Kinase Inhibition for Metastatic Renal Cancer
<p>Kaplan–Meier curves by treatment. The red line represents the ICI–ICI group, and the blue line represents the ICI–TKI group.</p>
Authors
- Shuya Kandori (ORCID: https://orcid.org/0000-0003-4621-8470)
- Hiromichi Sakurai
- Bunpei Isoda (ORCID: https://orcid.org/0009-0008-6483-3032)
- Hiromitsu Negoro (ORCID: https://orcid.org/0000-0003-1144-2755)
- Bryan J. Mathis (ORCID: https://orcid.org/0000-0002-9879-8289)
- Takamitsu Inoue (ORCID: https://orcid.org/0000-0002-1362-4344)
- Akira Joraku
- Tomoki Ishida
- Masanobu Shiga (ORCID: https://orcid.org/0000-0001-8610-0149)
- Hiroyuki Nishiyama (ORCID: https://orcid.org/0000-0001-7423-596X)
- Masahiro Iinuma (ORCID: https://orcid.org/0000-0003-1777-1525)
- Manabu Komine
- Masakazu Tsutsumi
- Shigeru Takahashi (ORCID: https://orcid.org/0009-0002-0028-1466)
- K Tanaka
- Akifumi Omiya
- Kotoe Matsuda
- Jun Miyazaki (ORCID: https://orcid.org/0000-0002-3618-0432)
Publication Details
- Published
- 2025-09-19
- DOI
- https://doi.org/10.1158/2767-9764.30162553
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00